Susie Wiles Denies Telling “Vanity Fair” That Elon Musk Is an ‘Avowed Ketamine User.’ There’s Reportedly a Recording of Her Saying It

Susie Wiles Refutes Claims Made by Vanity Fair Regarding Elon Musk’s Alleged Ketamine Usage

Susie Wiles, White House chief of staff, has denied making comments to Vanity Fair about Elon Musk’s purported drug habits, specifically referring to him as an ‘avowed ketamine user.’ Wiles stated to The New York Times that it was unjust for Vanity Fair to insinuate that she had accused Musk of consuming ketamine.

In a broad interview series with Vanity Fair, Wiles made several impactful statements about the second Trump administration, with one claim being that Elon Musk was known as an “avowed ketamine user.” However, she has since contradicted this remark. Speaking to The New York Times on Monday, December 15, Wiles, 68, affirmed that she never mentioned anything about the former DOGE advisor, 54, using ketamine. She emphasised, “That’s absurd. I wouldn’t have said it, and I wouldn’t be aware of it.”

The Times disclosed that Chris Whipple, who conducted the interviews with Wiles and penned the Vanity Fair article, played a recording of Wiles’ conversation about Musk. According to Whipple, Wiles allegedly remarked, “The challenge with Elon is keeping up with him. He’s an avowed ketamine [user]. And he sleeps in a sleeping bag in the EOB [Executive Office Building] in the daytime. And he’s an odd, odd duck, as I think geniuses are. You know, it’s not helpful, but he is his own person.”

Notably, Musk has been embroiled in allegations of substance abuse, particularly when showing support for Donald Trump’s 2024 re-election campaign, during which he reportedly donated significant sums towards Trump’s cause. Sources close to Musk suggested to the Times that he openly admitted to frequently using ketamine, with potential detrimental effects on his bladder as a consequence of regular consumption.

Despite Musk admitting to using ketamine in a March 2024 interview with Don Lemon, he claimed it was in small doses once every two weeks to alleviate depressive tendencies. Subsequently, following the Times’ exposé on his alleged drug usage, Musk shared results of a drug test demonstrating negative outcomes for ketamine, ecstasy, cocaine, and more.

Addressing the controversy, a spokesperson for the Times reaffirmed their stance on the reporting, insisting that Musk’s rebuttals did not invalidate their initial findings. Despite the intense scrutiny, Musk persisted in defending his clean drug test results, signalling a refusal to back down against media claims.

Following the publication of the Vanity Fair article, Wiles retaliated on social media, dismissing the piece as a biased attack on her and the Trump administration. She emphasised that the White House had achieved remarkable milestones under Trump’s guidance, disregarding the negative portrayal presented in the feature.

In solidarity with Wiles, White House press secretary Karoline Leavitt commended her leadership, attributing the administration’s success to her unwavering commitment. Leavitt underscored the President’s trust in Wiles, declaring her as a vital figure in their achievements thus far.

The ongoing dispute between Musk, Wiles, and the media outlets underscores the challenges of navigating public perception amidst allegations and denials. As the saga unfolds, it remains to be seen how each party will address the implications of these contentious claims.